Scientists have known for more than a decade that a protein associated with the HIV virus is good at crossing cell membranes, but they didnt know how it worked.
A multidisciplinary team from the University of Illinois has solved the mystery, and their findings could improve the design of therapeutic agents that cross a variety of membrane types.